Outline of a diabetes disease management model: Principles and applications

Diabetes Research and Clinical Practice

Volumn 50, Issue SUPPL. 3, 2000, Pages

  Palmer, Andrew J ^a,c   Brandt, Arno ^a   Gozzoli, Valerio ^a   Weiss, Christian ^a   Stock, Harald ^b   Wenzel, Helmut ^b  

^a IMIB   (Switzerland)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c IQVIA   (United States)

Author keywords

Computer model; Cost effectiveness; Diabetes; Health economics

Indexed keywords

ANTIDIABETIC AGENT;

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH MAINTENANCE ORGANIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIFE EXPECTANCY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; TREATMENT PLANNING; VASCULAR DISEASE;

COMPUTER SIMULATION; DATABASES; DIABETES MELLITUS; DOCUMENTATION; HUMANS; MODELS, STATISTICAL; SOFTWARE; TREATMENT OUTCOME;

EID: 0033749611     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(00)00216-3     Document Type: Article

References (12)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. The cost-effectiveness of different management strategies for type I diabetes: A Swiss perspective
3. Cardiovascular disease risk profiles
4. Probability of stroke: A risk profile from the Framingham study
5. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
6. Safety aspects of oral hypoglycaemic agents
7. Review: Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome
8. Lactic acidosis in patients with diabetes treated with metformin
9. Lactic acidosis in biguanide-treated diabetics: A review of 330 cases
10. What influence do hypoglycemic events have on the clinical and economic outcomes of intensive insulin therapy?
11. Cost-effectiveness of intensive therapy for type 1 diabetes changes depending on risk factors and degree of existing complications
12. Screening and intervention for microablbumniuria in insulin dependent diabetes - Is it worthwhile?